Hello:
Welcome to the HCV / HBV Advocate eblast for November 2011. Just a heads up that this month the AASLD Liver Meeting will be taking place in San Francisco and we will be providing onsite coverage and daily news updates. Stay tuned!!
This Month at the HCV and HBV Advocate(s)
Updated HBV Easy B Factsheets
Here's just a few
The HBV Journal Review, by Christine M. Kukka
-
Lab Tests Unable to Detect Hepatitis B in Patients Infected with Genotype G
-
Doctors Unaware HBV Is Spread Primarily Through Heterosexual Activity Among Adults
-
Hepatitis B Vaccine Recommended for Diabetics Under Age 60
-
More Drugs Found to Reactivate Hepatitis B in Patients with Current and Resolved Infections
-
Adefovir-Telbivudine Combination Effective in Lamivudine-Resistant Patients
-
Other Antiviral Combinations Appear Highly Effective in Hard-to-Treat Patients
-
Tenofovir Effective in Treating Patients with Entecavir Resistance
and more.................
Hepatitis C Support Project Training Manual
We are in the process of updating our extremely popular Training Manual, and have posted it in sections both to our Fact Sheet and our Trainer's Page
HBV and HCV Blog: Read about the latest and greatest in the news
 Hepatitis Transmission Risk Needs to Be Studied in Nail Salons, Barbershops
October 29
Notes from the Field: Risk Factors for Hepatitis C Virus Infections Among Young Adults --- Massachusetts, 2010
October 29
 CDC to Recommend Hepatitis B Vaccination in Diabetes
October 25
Gilead and GlobeImmune Ally to Develop HBV Vaccine for Use in Combination with Viread
October 25
Vertex Starts Global Phase 3b Study to Evaluate the Potential for People with Hepatitis C to Achieve a Viral Cure (SVR) with a Total Treatment Duration of 12 Weeks of INCIVEK™ Combination Therapy
October 24
Boehringer Ingelheim announces new data from hepatitis C virus portfolio
October 22
European studies on risks of hepatocellular carcinoma
October 21
Abbott says hepatitis C combo may be a blockbuster
October 21
Interim Phase IIb Data for Merck's VICTRELIS(TM) (boceprevir) in Patients Coinfected with Chronic Hepatitis C and HIV-1
October 20
New 4 x 6 Tattoo Postcard
Be Sure to check out the latest Tattoo Postcard from the HCV Advocate
To Download this Post Card, click here
Respectfully,
Alan
Alan Franciscus
Executive Director, Hepatitis C Support Project
Editor-in-Chief, HCV Advocate www.hcvadvocate.org
Editor-in-Chief, HBV Advocate www.hbvadvocate.org
**Questions and Comments: Questions and/or comments can be directed to alanfranciscus@hcvadvocate.org
**To receive the eblast in your email inbox simply send an e-mail to: listserv@list.hcvadvocate.org with nothing in the subject line and the following in the message body: subscribe emailalert. Make sure your email address is all lower case.
|
